Opeyemi Olabisi
@opeyemiolabisi.bsky.social
Physician-Scientist, Adult nephrologist. Passionately seeking prevention & cure for APOL1 kidney disease.
New in JASN: CARE shows a hybrid path to equitable APOL1-kidney disease (AMKD) screening + trial pipelines—community partnerships = reach, EHR/MD referrals = yield. journals.lww.com/jasn/pages/a... #Nephrology #KidneyDisease #APOL1 #AMKD #HealthEquity #ClinicalTrials #PrecisionMedicine #JASN
It was a pleasure to have Dr. Sanna-Cherchi @genetickidneydoc.bsky.social give an excellent, well-attended, Renal Grand Rounds at @dukekidney.bsky.social He is an embodiment of collaborative excellence💪🏾 @columbiakidney.bsky.social
I wasn’t born into wealth. I was born into the strength of Joshua Olabisi. His life story—Twice an Immigrant, Twice a Survivor—is full of grit, grace, and divine turns. Read it here: www.amazon.com/Twice-Immigr... #Legacy #Resilience #TwiceASurvivor My father’s story. My lifelong inspiration.
Twice an Immigrant, Twice a Survivor: The Miraculous Life of a Nurse Who Could Not Be Stopped
Amazon.com: Twice an Immigrant, Twice a Survivor: The Miraculous Life of a Nurse Who Could Not Be Stopped: 9798287609443: Olabisi, Joshua, Onime, Godfrey: Books
amazon.com
I am delighted to step into this exciting role. I look forward to advancing the clinical, research and educational missions of Duke Nephrology while supporting colleagues and inspiring learners!
Duke Kidney@dukekidney.bsky.social · last yr.We are excited to announce that Dr. Opeyemi Olabisi will be appointed as the next Chief of Nephrology in the Department of Medicine medicine.duke.edu/ne...
Simone @genetickidneydoc.bsky.social is a visionary and alliance-building, result-oriented scientist. His #rFSGS biobank will help the whole community. Refer your rFSGS patients to his registry. Together, we can conquer the #rFSGS menace.
Simone Sanna-Cherchi 🧬@genetickidneydoc.bsky.social · 2y agoOur #rFSGS biobank is growing and we welcome patients from all over the world! Please reach out to us if you are a patient or a physician caring for one. We are creating a resource for everyone to use with the goal of resolving this disease and find new cures. #KidneyMonth2025 #RareDisease #genetics
Our #rFSGS biobank is growing and we welcome patients from all over the world! Please reach out to us if you are a patient or a physician caring for one. We are creating a resource for everyone to use with the goal of resolving this disease and find new cures. #KidneyMonth2025 #RareDisease #genetics
rFSGS Initiative@rfsgsinitiative.bsky.social · 2y agoBuilding a biobank is key to finding new treatments for Recurrent Focal Segmental Glomerulosclerosis. If you or someone you know has #rFSGS and you want to learn how you can help by providing a biosample, email mb5150@cumc.columbia.edu. #KidneyMonth #KidneyTransplant #nephsky #medsky #skyneph
Congratulations Dr. @opeyemiolabisi.bsky.social for being elected to the American Society for Clinical Investigation (ASCI)! @the-asci.bsky.social medicine.duke.edu/news/two-duk...
Two Duke Nephrologists Elected to American Society for Clinical Investigation
Two Duke Department of Medicine faculty members, physician-scientists Opeyemi A. Olabisi, MD, PhD, and Tomokazu Souma, MD, PhD, are among the 2025 researchers elected to the American Society for Clini...
medicine.duke.edu
Congratulations to Dr. Tomasi @AleTomasiMD on being appointed as the chief nephrology fellow for the academic year 2025-2026.
New from Dr Anika Lucas and colleagues in Kidney360 2nd Trimester Kidney Function and Adverse Pregnancy Outcomes among Patients with Lupus journals.lww.com/kid...
Face-to-face interactions often facilitate collaboration and innovation. Therefore, @dukekidney.bsky.social research retreat focused on ways to increase purposeful interaction and collaboration. It was a time well spent!
Duke Kidney@dukekidney.bsky.social · 2y agowe had a wonderful nephrology divisional research retreat at @ncbiotech this past Friday
Happy to share this excellent editorial on our recent NEJM paper www.nejm.org/doi/10.1056/... by Simone @genetickidneydoc.bsky.social Simone you nailed it! www.nejm.org/doi/10.1056/... 🙏🏽
APOL1 Kidney Disease Variants — Information from West Africa at Last | NEJM
Chronic kidney disease (CKD) has a devastating effect on populations of African ancestry worldwide and disproportionately affects persons in West African countries,1 in whom CKD, once present, ofte...
nejm.org
I am delighted to be elected as a member of The American Society for Clinical Investigation! I’m thankful for my dedicated lab team, mentors, supportive family & colleagues @the-asci.bsky.social @dukekidney.bsky.social @dukemedschool.bsky.social
😁 Delighted to have my copy of ‘The Body’s Keepers’📔personally signed by author, Dr. Paul Kimmel🖋️ . This📔offers both a historical perspective➕personal look at development of kidney failure treatments, highlighting advances along w/ ongoing challenges | #KidneyHealth | #Innovation 🏥 👉🏽 t.ly/7UuYT
Summer Undergraduate Program in Kidney Science (SUPerKS) provides talented students the unique opportunity to explore research and physician-scientist careers in the kidney field with exposure to the practice of medicine. hopkinsmedicine.org/nephrology/e... Applications due by February 1, 2025
Summer Undergraduate Program in Kidney Science (SUPerKS)
hopkinsmedicine.org
JCI - Intestinal Cyp24a1 regulates vitamin D locally independent of systemic regulation by renal Cyp24a1 in mice www.jci.org/articles/vie...
JCI - Intestinal Cyp24a1 regulates vitamin D locally independent of systemic regulation by renal Cyp24a1 in mice
jci.org
We featured Chideraa Emma-Ugwuoke an outstanding PRIME PUMP scholar in the Student Corner of the OPSD December Newsletter. He worked with @opeyemiolabisi.bsky.social. Click the link to learn more about Chideraa's summer research experience @dukemedschool.bsky.social. mailchi.mp/duke/opsd-de...
How did the #APOL1 protective variant arise on the G2 haplotype? My initial guess was by independent mutational event, but look at this: a close proximity recombination event between G0 and G2. Read this report from Martin Pollak team to which we contributed #FSGS academic.oup.com/g3journal/ad...
The APOL1 p.N264K variant is co-inherited with the G2 kidney disease risk variant through a proximity recombination event
Abstract. Black Americans are three to four times more likely to develop nondiabetic kidney disease than other populations. Exclusively found in people of
academic.oup.com
Minus 10 days to the first ever, recurrent FSGS Conference! Registration is open for a few more days! Meet in person >60 patients/family members, Congressmen and Senators, and top scientists! ⬇️ @gbadegesinlab.bsky.social @kidneyomicsamps.bsky.social @opeyemiolabisi.bsky.social #rFSGS #nephsky
rFSGS Initiative@rfsgsinitiative.bsky.social · 2y agoYou're in luck! It's not too late to register for the Recurrent Focal Segmental Glomerulosclerosis (rFSGS) Conference. Visit our website and submit your registration today to join us on Dec. 9: www.scgcorp.com/rFSGS2024/Re... #rFSGS #rFSGSConference
@genetickidneydoc.bsky.social it was delightful working with you and your excellent team on this perspective.
Simone Sanna-Cherchi 🧬@genetickidneydoc.bsky.social · 2y agoFreshly published in JASN! Read our perspective on #APOL1 kidney risk variants and their implications, based on the recent H3Africa publication in the NEJM @opeyemiolabisi.bsky.social @gbadegesinlab.bsky.social journals.lww.com/jasn/citatio... www-nejm-org.ezproxy.cul.columbia.edu/doi/10.1056/...
The final version of our paper www.nejm.org/doi/10.1056/... One APOL1 risk variant is associated with CKD & FSGS. We have a solid basis for new mechanistic studies in our journey to find durable cure for APOL1 KD @opeyemiolabisi.bsky.social @kidneyomicsamps.bsky.social @genetickidneydoc.bsky.social
Are your patients with APOL1 kidney disease on optimal doses of ACEi/ARB? See my new commentary on an interesting mouse-based study from Pollak lab #APOL1 @genetickidneydoc.bsky.social @nephrosparks.bsky.social @kidneyomicsamps.bsky.social @gbadegesinlab.bsky.social @dukekidney.bsky.social
I look forward to participating in this important conference!
Simone Sanna-Cherchi 🧬@genetickidneydoc.bsky.social · 2y agoFor all new and old: REGISTER to our first ever, recurrent FSGS only, conference! Washington DC, December 9th. We just upsized the venue to accommodate more people! Unique participation of patients, scientists, public figures and more. Social dinner the night before for all! #rFSGS #Nephsky #Medsky
rFSGS is a major cause of kidney tx loss. There is a need for multidisciplinary rethinking of how we are going to solve this. We are all looking forward to the Dec 9th meeting in DC @genetickidneydoc.bsky.social @isgd.bsky.social #ASPN @opeyemiolabisi.bsky.social @kidneyomicsamps.bsky.social
Matt Sampson@kidneyomicsamps.bsky.social · 2y agoThis is a really important initiative being led by @genetickidneydoc.bsky.social @rfsgsinitiative.bsky.social and patient families. Recurrent FSGS is a very tough disease and I’m excited to be joining this conference to try to pitch in @gbadegesinlab.bsky.social #kidneyomics
Coming from X to Bsky and reconnecting with friends and colleagues who also fled the toxicity feels like post-apocalypse. You made it out of the cave/bunker and discovered that many of your loved ones also made it🤓
